GOSS - Wall Street Estimates - Gossamer Bio, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 1.205

-2.03 %

$ 273 M

Market Cap

-4.82

P/E

Price Target Average

348.13%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

27.58%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Gossamer Bio, Inc.

Wall Street analysts predict an average 1-year price target for GOSS of $5.4 , with forecasts ranging from a low of $2 to a high of $12 .

GOSS Lowest Price Target Wall Street Target

2 USD 65.98%

GOSS Average Price Target Wall Street Target

5.4 USD 348.13%

GOSS Highest Price Target Wall Street Target

12 USD 895.85%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free